156 related articles for article (PubMed ID: 20348246)
21. Findings from aCGH in patients with congenital diaphragmatic hernia (CDH): a possible locus for Fryns syndrome.
Kantarci S; Casavant D; Prada C; Russell M; Byrne J; Haug LW; Jennings R; Manning S; Boyd TK; Fryns JP; Holmes LB; Donahoe PK; Lee C; Kimonis V; Pober BR
Am J Med Genet A; 2006 Jan; 140(1):17-23. PubMed ID: 16333846
[TBL] [Abstract][Full Text] [Related]
22. Conformational differences between surface-bound and fluid-phase complement-component-C3 fragments. Epitope mapping by cDNA expression.
Nilsson B; Grossberger D; Nilsson Ekdahl K; Riegert P; Becherer DJ; Nilsson UR; Lambris JD
Biochem J; 1992 Mar; 282 ( Pt 3)(Pt 3):715-21. PubMed ID: 1372802
[TBL] [Abstract][Full Text] [Related]
23. Recessive PIGN Mutations in Fryns Syndrome: Evidence for Genetic Heterogeneity.
Thompson MD; Cole DE
Hum Mutat; 2016 Jul; 37(7):621. PubMed ID: 27300081
[No Abstract] [Full Text] [Related]
24. A CD46-like molecule functional in teleost fish represents an ancestral form of membrane-bound regulators of complement activation.
Tsujikura M; Nagasawa T; Ichiki S; Nakamura R; Somamoto T; Nakao M
J Immunol; 2015 Jan; 194(1):262-72. PubMed ID: 25452563
[TBL] [Abstract][Full Text] [Related]
25. Congenital diaphragmatic hernia, coarse facies, and acral hypoplasia: Fryns syndrome.
Bamforth JS; Leonard CO; Chodirker BN; Chitayat D; Gritter HL; Evans JA; Keena B; Pantzar T; Friedman JM; Hall JG
Am J Med Genet; 1989 Jan; 32(1):93-9. PubMed ID: 2650550
[TBL] [Abstract][Full Text] [Related]
26. Fryns syndrome without diaphragmatic hernia. Report on a new case and review of the literature.
Alessandri L; Brayer C; Attali T; Samperiz S; Tiran-Rajaofera I; Ramful D; Pilorget H
Genet Couns; 2005; 16(4):363-70. PubMed ID: 16440878
[TBL] [Abstract][Full Text] [Related]
27. Impaired mesenchymal cell function in Gata4 mutant mice leads to diaphragmatic hernias and primary lung defects.
Jay PY; Bielinska M; Erlich JM; Mannisto S; Pu WT; Heikinheimo M; Wilson DB
Dev Biol; 2007 Jan; 301(2):602-14. PubMed ID: 17069789
[TBL] [Abstract][Full Text] [Related]
28. Molecular cloning, expression and characterization of the rat analogue of human membrane cofactor protein (MCP/CD46).
Mead R; Hinchliffe SJ; Morgan BP
Immunology; 1999 Sep; 98(1):137-43. PubMed ID: 10469244
[TBL] [Abstract][Full Text] [Related]
29. Functional analysis of Cobra Venom Factor/human C3 chimeras transiently expressed in mammalian cells.
Kölln J; Matzas M; Jänner N; Mix T; Klensang K; Bredehorst R; Spillner E
Mol Immunol; 2004 May; 41(1):19-28. PubMed ID: 15140572
[TBL] [Abstract][Full Text] [Related]
30. A novel complement C3 like gene (Lv-C3L) from Litopenaeus vannamei with bacteriolytic and hemolytic activities and its role in antiviral immune response.
Liu Y; Song Q; Li D; Zou R; Zhang Y; Hao S; Geng X; Sun J
Fish Shellfish Immunol; 2019 Aug; 91():376-387. PubMed ID: 31125666
[TBL] [Abstract][Full Text] [Related]
31. Targeted disruption of the murine gene coding for the third complement component (C3).
Pekna M; Hietala MA; Rosklint T; Betsholtz C; Pekny M
Scand J Immunol; 1998 Jan; 47(1):25-9. PubMed ID: 9467654
[TBL] [Abstract][Full Text] [Related]
32. Expression of complement component 3 (C3) from an adenovirus leads to pathology in the murine retina.
Cashman SM; Desai A; Ramo K; Kumar-Singh R
Invest Ophthalmol Vis Sci; 2011 May; 52(6):3436-45. PubMed ID: 21357400
[TBL] [Abstract][Full Text] [Related]
33. Activation of the alternative pathway of human complement by autologous cells expressing transmembrane recombinant properdin.
Vuagnat BB; Mach J; Le Doussal JM
Mol Immunol; 2000 Jun; 37(8):467-78. PubMed ID: 11090881
[TBL] [Abstract][Full Text] [Related]
34. Murine gammaherpesvirus 68 encodes a functional regulator of complement activation.
Kapadia SB; Molina H; van Berkel V; Speck SH; Virgin HW
J Virol; 1999 Sep; 73(9):7658-70. PubMed ID: 10438856
[TBL] [Abstract][Full Text] [Related]
35. Anti-complement activity of oleanolic acid: an inhibitor of C3-convertase of the classical complement pathway.
Kapil A; Sharma S
J Pharm Pharmacol; 1994 Nov; 46(11):922-3. PubMed ID: 7897600
[TBL] [Abstract][Full Text] [Related]
36. Recessive loss of function PIGN alleles, including an intragenic deletion with founder effect in La Réunion Island, in patients with Fryns syndrome.
Alessandri JL; Gordon CT; Jacquemont ML; Gruchy N; Ajeawung NF; Benoist G; Oufadem M; Chebil A; Duffourd Y; Dumont C; Gérard M; Kuentz P; Jouan T; Filippini F; Nguyen TTM; Alibeu O; Bole-Feysot C; Nitschké P; Omarjee A; Ramful D; Randrianaivo H; Doray B; Faivre L; Amiel J; Campeau PM; Thevenon J
Eur J Hum Genet; 2018 Mar; 26(3):340-349. PubMed ID: 29330547
[TBL] [Abstract][Full Text] [Related]
37. Formation of high affinity C5 convertase of the classical pathway of complement.
Rawal N; Pangburn MK
J Biol Chem; 2003 Oct; 278(40):38476-83. PubMed ID: 12878586
[TBL] [Abstract][Full Text] [Related]
38. Lessons from functional and structural analyses of disease-associated genetic variants in the complement alternative pathway.
Rodríguez de Córdoba S; Harris CL; Morgan BP; Llorca O
Biochim Biophys Acta; 2011 Jan; 1812(1):12-22. PubMed ID: 20837143
[TBL] [Abstract][Full Text] [Related]
39. Prenatal and postnatal findings in five cases of Fryns syndrome.
Peron A; Bedeschi MF; Fabietti I; Baffero GM; Fogliani R; Ciralli F; Mosca F; Rizzuti T; Leva E; Lalatta F
Prenat Diagn; 2014 Dec; 34(12):1227-30. PubMed ID: 24996149
[No Abstract] [Full Text] [Related]
40. Active sites in complement component C3 mapped by mutations at indels.
Ogata RT; Ai R; Low PJ
J Immunol; 1998 Nov; 161(9):4785-94. PubMed ID: 9794410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
